A significant breakthrough in cancer research is emerging with the use of mini-antibodies to reactivate dysfunctional p53. This vital malignant protector protein is frequently disabled in several forms of tumors, https://siambookmark.com/story21976458/nanobodies-revive-the-p53-protein-a-promising-hope-for-malignant-therapy